The primary goals of the Cellular Biochemistry Group are to determine the composition and functional features of the supramolecular complex of proteins that calcifies, and how cells regulate this process. Towards these aims, cell cultures that support and form mineralized tissues were established for biochemical analysis, and for studies at the genomic level in collaboration with Drs. Marian F. Young and Larry W. Fisher. Studies were initiated to characterize the biosynthetic products of a cell line BBE (bovine bone endothelial cells) since the vasculature has been shown to influence bone metabolism. It was found that these cells synthesize fibronectin, type I collagen, osteonectin and thrombospondin, and induce the preosteoclastic cell line, FLG 29.1, to attach and multinucleate. Further characterization of FLG 29.1 also indicated that they synthesize bone sialoprotein, as has been observed in bona fide osteoclasts by in situ hybridization and immunohistochemistry. Continued analysis of cell- matrix interactions indicate that the two small proteoglycans found in bone, biglycan and decorin, inhibit bone cell attachment to some but not all RGD-containing proteins, suggesting that osteoblastic cells can modulate their attachment to the surrounding environment by the production of such inhibitory molecules. Cell attachment to bone matrix proteins was also found to depend on the phenotypic traits and maturational stage of cloned mouse marrow stromal fibroblasts. Lastly, studies utilizing bone- forming cultures from patients with different forms of osteogenesis imperfecta indicates that there is a major change in the stoichiometry of extracellular matrix proteins, irrespective of the detectability of a collagen mutation. While synthesis of versican, biglycan, decorin and osteonectin are decreased, thrombospondin and fibronectin are increased. These changes may contribute significantly to cell-matrix interactions and may play a role in the pathophysiology of this brittle bone disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000380-12
Application #
5201773
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
National Institute of Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Padmanabhan, Raji; Chen, Kevin G; Gillet, Jean-Pierre et al. (2012) Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells 30:2175-87
Balakumaran, Arun; Robey, Pamela Gehron; Fedarko, Neal et al. (2010) Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn 10:465-80
Mazar, Julia; Thomas, Molly; Bezrukov, Ludmila et al. (2009) Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells. J Biol Chem 284:22022-8
Pawelczyk, Edyta; Jordan, Elaine K; Balakumaran, Arun et al. (2009) In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One 4:e6712
Inkson, Colette A; Ono, Mitsuaki; Kuznetsov, Sergei A et al. (2008) TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem 104:1865-78
Tsutsui, T W; Riminucci, M; Holmbeck, Kenn et al. (2008) Development of craniofacial structures in transgenic mice with constitutively active PTH/PTHrP receptor. Bone 42:321-31
Pawelczyk, Edyta; Arbab, Ali S; Chaudhry, Aneeka et al. (2008) In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells 26:1366-75
Bianco, Paolo; Robey, Pamela Gehron; Simmons, Paul J (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313-9
Mankani, Mahesh H; Kuznetsov, Sergei A; Robey, Pamela Gehron (2007) Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. Exp Hematol 35:995-1004
Hart, Elizabeth S; Kelly, Marilyn H; Brillante, Beth et al. (2007) Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res 22:1468-74

Showing the most recent 10 out of 71 publications